35 /100
MEDIUM RISK
Score updated May 30, 2026

LIPO — Lipella Pharmaceuticals Inc. Dilution Risk Tracker

Track LIPO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LIPO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split 65%
• 50-day avg $0.07 below $1 exchange minimum
• 8 months cash with weak price
📉 Score Deterioration 40%
• Score rose 15 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (8mo)
🔔 Track LIPO — Get forecast alerts →

💹 Market Data

Market Cap$462.1K
Shares Outstanding4.62M
Float4.33M
Cash$1.86M
Debt$264.1K
Short InterestN/A

🏛 Institutional Holdings

1.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track LIPO for full holder detail →

📉 Short Interest

Short Interest2.6K
Days to Cover1.0
% of Float0.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track LIPO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LIPO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for LIPO
📊 LIPO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LIPO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.